Brain Tumor Pathology

Papers
(The median citation count of Brain Tumor Pathology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Clinical, histopathological and molecular risk factors for recurrence of pilocytic astrocytomas: brainstem/spinal location, nestin expression and gain of 7q and 19 are associated with early tumor recu45
Intraspinal ASPSCR1::TFE3 rearranged tumor with nerve differentiation23
Preface for Brain Tumor Pathology vol.41 issue 220
Droplet digital PCR assay for detecting TERT promoter mutations in patients with glioma15
Double-hit primary central nervous system lymphoma with histogenetically proven bone marrow infiltration: a case report and a review of the literature14
The oligodendroglial histological features are not independently predictive of patient prognosis in lower-grade gliomas14
Correlation of MTAP immunohistochemical deficiency with CDKN2A homozygous deletion and clinicopathological features in pleomorphic xanthoastrocytoma14
Central nervous system ALK-negative anaplastic large cell lymphoma with IRF4/DUSP22 rearrangement14
Beyond the WHO 2021 classification of the tumors of the central nervous system: transitioning from the 5th edition to the next13
IDH wild-type lower-grade gliomas with glioblastoma molecular features: a systematic review and meta-analysis13
A clinicopathological analysis of supratentorial ependymoma, ZFTA fusion-positive: utility of immunohistochemical detection of CDKN2A alterations and characteristics of the immune microenvironment12
Histopathological predictors of progression-free survival in atypical meningioma: a single-center retrospective cohort and meta-analysis11
Primary central nervous system lymphoma: clinicopathological and genomic insights for therapeutic development10
Lynch syndrome-associated chordoma with high tumor mutational burden and significant response to immune checkpoint inhibitors10
Correction: Beyond the WHO 2021 classification of the tumors of the central nervous system: transitioning from the 5th edition to the next10
FISH analysis reveals CDKN2A and IFNA14 co-deletion is heterogeneous and is a prominent feature of glioblastoma10
Pediatric diffuse glioma with EP300::BCOR fusion manifesting as low-grade epilepsy-associated neuroepithelial tumor: a case presentation8
Comparative analyses of immune cells and alpha-smooth muscle actin-positive cells under the immunological microenvironment between with and without dense fibrosis in primary central nervous system lym8
Predicting BRAF V600E mutation in glioblastoma: utility of radiographic features8
Tectal glioma: clinical, radiological, and pathological features, and the importance of molecular analysis7
Three-dimensional visualization of human brain tumors using the CUBIC technique7
The 2021 WHO classification of tumors, 5th edition, central nervous system tumors: the 10 basic principles7
Preface for Brain Tumor Pathology vol. 39 issue 27
Revisiting vimentin: a negative surrogate marker of molecularly defined oligodendroglioma in adult type diffuse glioma7
Revisiting the definition of glioma recurrence based on a phylogenetic investigation of primary and re-emerging tumor samples: a case report6
Easy-to-use machine learning system for the prediction of IDH mutation and 1p/19q codeletion using MRI images of adult-type diffuse gliomas6
Spontaneous malignant transformation of trigeminal schwannoma: consideration of responsible gene alterations for tumorigenesis—a case report6
Clinical and radiological features of intracranial ancient schwannomas: a single-institution, retrospective analysis5
Aggressive nonfunctioning pituitary neuroendocrine tumors5
Progression of long-term “untreated” oligodendroglioma cases: possible contribution of genomic instability5
Integrated analysis of multiple methods reveals characteristics of the immune microenvironment in medulloblastoma5
Utility of genome-wide DNA methylation profiling for pediatric-type diffuse gliomas5
Spinal cord astroblastoma with EWSR1-BEND2 fusion classified as HGNET-MN1 by methylation classification: a case report5
Timing of H3K27me3 loss in secondary anaplastic meningiomas5
Status of alternative angiogenic pathways in glioblastoma resected under and after bevacizumab treatment5
Association between IDH mutational status and tumor-associated epilepsy or venous thromboembolism in patients with grade II and III astrocytoma5
Clinical and radiological findings of glioblastomas harboring a BRAF V600E mutation5
Astroblastoma with MN1::BEND2 in an elderly patient: A case report and review of the literature5
Impact of tumor markers on diagnosis, treatment and prognosis in CNS germ cell tumors: correlations with clinical practice and histopathology4
Preface4
Rise of oligodendroglioma hypermutator phenotype from a subclone harboring TP53 mutation after TMZ treatment4
An extracranial CNS presentation of the emerging “intracranial” mesenchymal tumor, FET: CREB-fusion positive4
Clinicopathological risk factors for a poor prognosis of primary central nervous system lymphoma in elderly patients in the Tohoku and Niigata area: a multicenter, retrospective, cohort study of the T4
A primary DICER1-sarcoma with KRAS and TP53 mutations in a child with suspected ECCL4
Emerging glioneuronal and neuronal tumors: case-based review4
Liquid biomarkers in glioma3
MAPK pathway alterations in polymorphous low-grade neuroepithelial tumor of the young: diagnostic considerations3
Visualizing the endothelial glycocalyx in human glioma vasculature3
Recent advances in liquid biopsy of central nervous system lymphomas: case presentations and review of the literature3
Touch imprint cytology is useful for the intraoperative pathological diagnosis of PitNETs’ surgical margins3
Correction to: Epithelioid inflammatory myofibroblastic sarcoma with VCL–ALK fusion of central nervous system: case report and brief review of the literature3
PBRM1 and BAP1: novel genetic mutations in malignant transformation of craniopharyngioma—a case report3
Role of proliferative marker index and KBTBD4 mutation in the pathological diagnosis of pineal parenchymal tumors3
0.10035514831543